Bempedoic acid cut CV events and may also dampen age-related inflammation
Louis shares Gokhan Can's summary of bempedoic acid in 4,206 statin-intolerant primary prevention patients: the primary composite fell 30%, MI 39%, and all-cause mortality 27%. It lowers LDL by 21.3% and hsCRP by 21.5%, and inhibits ACLY, which drives senescence inflammation in aged mice.




